Pancreatic Cancer Research

ResearcherCentral European Institute of Technology – Masaryk UniversityNo recent work listed

Natalia Gabło

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5090600806. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 1 paper

Papers 4

  1. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection. Co-author DOI 10.3390/jcm9082440↗
  2. Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer. Co-author DOI 10.2174/1389202921666191217095017↗
  3. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection Co-author PMID 31064193↗
  4. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical… First author DOI 10.21873/cgp.20090↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ondřej Slabý · 4 shared papers, 2018–2020 · strength 0.41
  2. Zdeněk Kala · 4 shared papers, 2018–2020 · strength 0.41
  3. Igor Kišš · 4 shared papers, 2018–2020 · strength 0.41
  4. Vladimír Procházka · 3 shared papers, 2018–2020 · strength 0.31
  5. Jan Hlavsa · 3 shared papers, 2018–2020 · strength 0.29
  6. Martin Loveček · 1 shared paper, 2020 · strength 0.10
  7. Ioana Berindan‐Neagoe · 1 shared paper, 2020 · strength 0.10
  8. Markéta Hermanová · 1 shared paper, 2018 · strength 0.08
  9. Petra Vychytilova‐Faltejskova · 1 shared paper, 2018 · strength 0.08
  10. Petr Karásek · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.